These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35273322)

  • 41. Use of the Migraine Disability Assessment Questionnaire in children and adolescents with headache: an Italian pilot study.
    D'Amico D; Grazzi L; Usai S; Andrasik F; Leone M; Rigamonti A; Bussone G
    Headache; 2003; 43(7):767-73. PubMed ID: 12890131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of temporomandibular joint disorder in headache patients.
    Memmedova F; Emre U; Yalın OÖ; Doğan OC
    Neurol Sci; 2021 Nov; 42(11):4503-4509. PubMed ID: 33604763
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The quality of diagnosis and management of migraine and tension-type headache in three social groups in Russia.
    Lebedeva ER; Kobzeva NR; Gilev DV; Olesen J
    Cephalalgia; 2017 Mar; 37(3):225-235. PubMed ID: 27053061
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Migraine headache and mitochondrial DNA abnormality].
    Koga Y; Nataliya P
    Nihon Rinsho; 2005 Oct; 63(10):1720-6. PubMed ID: 16218381
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of primary chronic headache in a population-based sample of 30- to 44-year-old persons. The Akershus study of chronic headache.
    Grande RB; Aaseth K; Gulbrandsen P; Lundqvist C; Russell MB
    Neuroepidemiology; 2008; 30(2):76-83. PubMed ID: 18277081
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of primary headaches in an urban slum in Enugu South East Nigeria: a door-to-door survey.
    Ezeala-Adikaibe BA; Onyekonwu C; Okudo G; Onodugo O; Ekenze S; Orjioke C; Chime P; Ezeanosike O; Mbadiwe N; Chikani M; Okwara C; Ulasi I; Ijoma U
    Headache; 2014; 54(10):1601-10. PubMed ID: 25339250
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine.
    Ford JH; Kurth T; Starling AJ; Ayer DW; Wietecha LA; Port MD; Rettiganti M; Ruff DD
    Headache; 2020 Nov; 60(10):2304-2319. PubMed ID: 33249580
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnosis and Management of Headache: A Review.
    Robbins MS
    JAMA; 2021 May; 325(18):1874-1885. PubMed ID: 33974014
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies.
    Smitherman TA; Burch R; Sheikh H; Loder E
    Headache; 2013 Mar; 53(3):427-36. PubMed ID: 23470015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Joint hypermobility syndrome: A common clinical disorder associated with migraine in women.
    Bendik EM; Tinkle BT; Al-shuik E; Levin L; Martin A; Thaler R; Atzinger CL; Rueger J; Martin VT
    Cephalalgia; 2011 Apr; 31(5):603-13. PubMed ID: 21278238
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Disability in chronic migraine patients with medication overuse: treatment effects at 1-year follow-up.
    Grazzi L; Andrasik F; D'Amico D; Usai S; Kass S; Bussone G
    Headache; 2004; 44(7):678-83. PubMed ID: 15209690
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic daily headache: transformational migraine, chronic migraine, and related disorders.
    Saper JR
    Curr Neurol Neurosci Rep; 2008 Mar; 8(2):100-7. PubMed ID: 18460277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mitochondrial dysfunction and migraine: evidence and hypotheses.
    Sparaco M; Feleppa M; Lipton RB; Rapoport AM; Bigal ME
    Cephalalgia; 2006 Apr; 26(4):361-72. PubMed ID: 16556237
    [TBL] [Abstract][Full Text] [Related]  

  • 54. What Will it Take to Move the Needle for Headache Disorders? An Advocacy Perspective.
    Shapiro RE
    Headache; 2020 Oct; 60(9):2059-2077. PubMed ID: 32813900
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of headache in Puerto Rico.
    Miranda H; Ortiz G; Figueroa S; Peña D; Guzmán J
    Headache; 2003; 43(7):774-8. PubMed ID: 12890132
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The prevalence of migraine in restless legs syndrome.
    Gozubatik-Celik G; Benbir G; Tan F; Karadeniz D; Goksan B
    Headache; 2014 May; 54(5):872-7. PubMed ID: 24433539
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health Studies.
    Burch R; Rizzoli P; Loder E
    Headache; 2018 Apr; 58(4):496-505. PubMed ID: 29527677
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Opioid use and dependence among persons with migraine: results of the AMPP study.
    Buse DC; Pearlman SH; Reed ML; Serrano D; Ng-Mak DS; Lipton RB
    Headache; 2012 Jan; 52(1):18-36. PubMed ID: 22268775
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stigma and Migraine: Developing Effective Interventions.
    Parikh SK; Kempner J; Young WB
    Curr Pain Headache Rep; 2021 Dec; 25(11):75. PubMed ID: 34873646
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The prevalence, course and clinical correlates of migraine in Parkinson's disease: A multicentre case-controlled study.
    Suzuki K; Okuma Y; Uchiyama T; Miyamoto M; Sakakibara R; Shimo Y; Hattori N; Kuwabara S; Yamamoto T; Kaji Y; Hirano S; Suzuki S; Haruyama Y; Kobashi G; Hirata K;
    Cephalalgia; 2018 Aug; 38(9):1535-1544. PubMed ID: 29073773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.